Table 2.
Characteristics of VTE/AT episodes in patients with kidney cancer
Parameter | Subparameter | n = 12 |
---|---|---|
Type VTE/ AT | PE | 33.3% (n = 4) |
DVT | 8.3% (n = 1) | |
Other forms of VTE: visceral, associated with catheter… | 33.3% (n = 4) | |
Cerebral stroke | 8.3% (n = 1) | |
Acute myocardial infarction | 8.3% (n = 1) | |
Other forms of AT | 8.3% (n = 1) | |
Tumor reevaluation at diagnosis of VTE/AT | Complete response | 0% (n = 0) |
Partial response | 0% (n = 0) | |
Stable disease | 41.7% (n = 5) | |
Unconfirmed progression | 8.3% (n = 1) | |
Confirmed progression | 41.7% (n = 5) | |
Not reevaluated | 8.3% (n = 1) | |
VTE/AT presentation | Incidental | 41.7% (n = 5) |
Symptomatic | 58.3% (n = 7) | |
Setting of VTE/AT diagnosis | Outpatient | 83.3% (n = 10) |
In-patient | 16.7% (n = 2) | |
Setting of VTE/AT management | Outpatient | 50% (n = 6) |
In-patient | 50% (n = 6) |
AT arterial thrombosis, DVT deep vein thrombosis, PE pulmonary embolism, VTE venous thromboembolism